chloroquine has been researched along with ergoline in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andressen, KW; Brevik, CH; Krobert, KA; Levy, FO; Manfra, O; Ulsund, AH; Vanhoenacker, P | 1 |
Cao, L; Guo, YH; Leng, ZG; Lin, SJ; Shang, HB; Wu, ZB; Wu, ZR; Zhang, X; Zhang, Y; Zhao, WG | 1 |
2 other study(ies) available for chloroquine and ergoline
Article | Year |
---|---|
The atypical antipsychotics clozapine and olanzapine promote down-regulation and display functional selectivity at human 5-HT7 receptors.
Topics: Antipsychotic Agents; Arrestins; Benzodiazepines; beta-Arrestins; Cells, Cultured; Chloroquine; Clozapine; Down-Regulation; Drug Inverse Agonism; Ergolines; HEK293 Cells; Humans; Ligands; Lysosomes; Olanzapine; Phenols; Radioligand Assay; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Signal Transduction; Sulfonamides | 2015 |
Pituitary Tumor Suppression by Combination of Cabergoline and Chloroquine.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cabergoline; Cell Death; Cells, Cultured; Chloroquine; Ergolines; Female; Hep G2 Cells; Humans; Mice; Mice, Nude; Pituitary Neoplasms; Prolactinoma; Rats; Rats, Inbred F344; Xenograft Model Antitumor Assays | 2017 |